| D007150 |
Immunohistochemistry |
Histochemical localization of immunoreactive substances using labeled antibodies as reagents. |
Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling |
|
| D008213 |
Lymphocyte Activation |
Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. |
Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte |
|
| D000097763 |
Polypeptide N-acetylgalactosaminyltransferase |
Family of enzymes that catalyze the formation of GalNAcAlpha1-serine/threonine linkages in glycoproteins. |
Galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase,Globoside Synthase,Globoside beta GalNAc Transferase,Protein-UDPacetylgalactosaminyltransferase,(1-3)-N-acetyl-beta-galactosaminyltransferase,(1-4)-N-acetyl-beta-D-galactosaminyltransferase,4-GalNActransferase,GalNAc-T1,GalNAc-T10,GalNAc-T2,GalNAc-T3,GalNAc-T4,GalNAc-T5,GalNAc-T8,GalNAc-transferase,GalNAcT-1,GalNAcT-2,GalNAcT-4,GalNAcT-8,UDP-GPAGAT,UDP-GalNAc-beta-galactose beta 1,4-N-acetylgalactosaminyltransferase,UDP-GalNAc-polypeptide N-acetylgalactosaminyltransferase,UDP-N-acetyl-D-galactosamine polypeptide N-acetylgalactosaminyltransferase-T4,UDP-N-acetylgalactosamine mucin transferase,UDP-N-acetylgalactosamine-beta-galactose beta 1,4-N-acetylgalactosaminyltransferase,UDP-N-acetylgalactosamine-globoside beta-N-acetylgalactosaminyltransferase,UDP-N-acetylgalactosamine-globosidetriaosylceramide beta-3-N-acetylgalactosaminyltransferase,UDP-N-acetylgalactosamine-polypeptide N-acetylgalactosamine transferase,UDPacetylgalactosamine-galactosyl-galactosyl-glucosylceramide beta-N-acetyl-D-galactosaminyltransferase,UDPacetylgalactosamine-protein acetylgalactosaminyltransferase,beta-1,4-N-acetylgalactosaminyltransferase,beta-N-acetylgalactosaminyltransferase,beta1,6N-acetylgalactosaminyltransferase,polypeptide N-acetylgalactosaminyltransferase 1,polypeptide N-acetylgalactosaminyltransferase 10,polypeptide N-acetylgalactosaminyltransferase 2,polypeptide N-acetylgalactosaminyltransferase 3,polypeptide N-acetylgalactosaminyltransferase 4,polypeptide N-acetylgalactosaminyltransferase 5,polypeptide N-acetylgalactosaminyltransferase 8,pp-GalNAc-T10,ppGalNAc-T,Synthase, Globoside |
|
| D000818 |
Animals |
Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. |
Animal,Metazoa,Animalia |
|
| D001402 |
B-Lymphocytes |
Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. |
B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent |
|
| D017209 |
Apoptosis |
A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. |
Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis |
|
| D017350 |
N-Acetylgalactosaminyltransferases |
Enzymes that catalyze the transfer of N-acetylgalactosamine from a nucleoside diphosphate N-acetylgalactosamine to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-. |
N-Acetylgalactosamine Transferases,N Acetylgalactosamine Transferases,N Acetylgalactosaminyltransferases,Transferases, N-Acetylgalactosamine |
|
| D051379 |
Mice |
The common name for the genus Mus. |
Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus |
|
| D056724 |
Immunity, Humoral |
Antibody-mediated immune response. Humoral immunity is brought about by ANTIBODY FORMATION, resulting from TH2 CELLS activating B-LYMPHOCYTES, followed by COMPLEMENT ACTIVATION. |
Humoral Immune Response,Humoral Immune Responses,Humoral Immunity,Immune Response, Humoral,Immune Responses, Humoral,Response, Humoral Immune |
|
| D018345 |
Mice, Knockout |
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes. |
Knockout Mice,Mice, Knock-out,Mouse, Knockout,Knock-out Mice,Knockout Mouse,Mice, Knock out |
|